ReVia 50 mg Oral Tablet
RxNorm 1483746
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 1483746 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: ReVia 50 mg Oral Tablet.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SBDPrescribable
Semantic Branded Drug (SBD):
Naltrexone hydrochloride 50 mg Oral Tablet [ReVia]
(Atom ID: 12368830)
PSNPrescribable
Prescribable Name (PSN):
ReVia 50 mg Oral Tablet
(Atom ID: 6358537)
SYPrescribable
Synonym (SY):
ReVia 50 mg Oral Tablet
(Atom ID: 1154928)
Patient Education
Naltrexone
Naltrexone is used along with counseling and social support to help people who have stopped drinking alcohol and using street drugs continue to avoid drinking or using drugs. Naltrexone should not be used to treat people who are still using street drugs or drinking large amounts of alcohol. Naltrexone is in a class of medications called opiate antagonists. It works by decreasing the craving for alcohol and blocking the effects of opiate medications and opioid street drugs.
[Learn More]
* Please review the disclaimer below.